Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 8, 2004, Pages 655-661

  Osborne, Raymond ^a   Covens, Allan ^a   Merchandani, D E ^a   Gerulath, Alan ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Gestational trophoblastic disease; Gonadotropins, chorionic, human; Paclitaxel; Pregnancy, molar; Trophoblastic cancer; Trophoblastic neoplasms

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; VINBLASTINE;

ADULT; CANADA; CANCER ADJUVANT THERAPY; CANCER CENTER; CASE REPORT; CONFERENCE PAPER; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HIGH RISK PATIENT; HUMAN; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RECURRENT CANCER; RELAPSE; THROMBOCYTOPENIA; TROPHOBLASTIC TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIOCARCINOMA; CISPLATIN; ETOPOSIDE; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PREGNANCY; SALVAGE THERAPY; UTERINE NEOPLASMS;

EID: 4344586678     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Newlands ES, Bagshawe KD, Begent RHJ: Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumours, 1979-1989. Br J Obstet Gynaecol 1991;98:550-557
2. Bagshawe KD: Treatment of high-risk choriocarcinoma. J Reprod Med 1984;29:813-820
3. Bower M, Newlands ES, Holden L: EMA/CO for high risk gestational trophoblastic tumours: Results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-2643
4. Kim SJ, Bae SN, Kim JH: Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998;71:247-253
5. Newlands E, Mulholland PJ, Holden L, et al: Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and for patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;18:854-859
6. Termfunguanglert W, Kudelka A, Piamsomboon S, et al: Remission of refractory gestational trophoblastic disease with high-dose paclitaxel. Anticancer Drugs 1996;7:503-506
7. Piamsomboon S, Kudelka A, Terrungruanglert W, et al: Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): First report and review of literature. Eur J Gynaecol Oncol 1997;18:453-456
8. Garris PD, Gallup DG, Melton K: Long-term remission of previously resistant choriocarcinoma with a combination of etoposide, ifosfamide and cisplatin. Gynecol Oncol 1995;57:254-256
9. Sutton GP, Soper JT, Blessing JA: Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Obstet Gynecol 1992;167:489-495
10. Lurain JR: Advances in management of high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:451-459
11. Jones WB, Shapiro SJ: Treatment of resistant gestational choriocarcinoma with Taxol: A report of two cases. Gynecol Oncol 1996;61:126-130
12. Kohn EC, Bicher A, Link C, et al: Dose-intense taxol: High response rate in patients with platinum-resistant ovarian cancer. J Natl Cancer Inst 1994;86:18-24
13. Eisenhauer EA, Swenerton KD, Gianni L, et al: European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion. J Clin Oncol 1994;12:2654-2666
14. Koechli O, Schaer G, Sevin B, et al: In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms. Anitcancer Drugs 1995;6:94-100
15. Motzer RJ, Schwartz LH, Hutter HS, et al: Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1994;21:2277-2283
16. Bunnell CA, Buswell L, Berkowitz R, et al: A phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. Cancer 1998;82:561-566
17. Sandler AB, Fox S, Williams SD, et al: A phase II trial of paclitaxel in refractory germ cell tumors. Cancer 1998;82:1381-1386
18. Rustin GJS, Newlands ES, Lutz J-M: Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumours (GTT) increases the incidence of second tumours. J Clin Oncol 1996;14:2769-2773
19. Wiltshaw E: Ovarian cancer trials at the Royal Marsden. Cancer Treat Rev 1985;12:67-71
20. Crawford RA, Newlands E, Rustin GJ, et al: Gestational trophoblastic disease with liver metastases: The Charing Cross experience. Br J Obstet Gynaecol 1997;104:105-109
21. Evans AC, Soper JT, Clarke-Pearson DL, et al: Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol 1995;59:226-230
22. Jones WB, Wagner-Reiss RK, Lewis JL: Intracranial choriocarcinoma. Gynecol Oncol 1990;38:234-243
23. Small W, Lurain J, Shetty RM, et al: Gestational trophoblastic disease metastatic to the brain. Radiology 1996;200:277-280
24. Gerson R, Serrano A, Del Carmen Bello M, et al: Response of choriocarcinoma to paclitaxel: Case report and review of resistance. Eur J Gynaecol Oncol 1997;18:108-110
25. Farghaly SA: A possible chemotherapeutic response by paclitaxel and other antineoplastic agents in treatment of choriocarcinoma in vitro. Am J Obstet Gynecol 1996;175:1075-1077
26. McNally O, Tran M, Fortune D, et al: Successful treatment of mother and baby with metastatic choriocarcinoma. Int J Gynecol Oncol 2002;12:394-398
27. Newlands E: Management of High-Risk GTN Patients Following EP/EMA Failure. London, 2000
28. Sung H, Pao-chen W, Yang H: Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. Am J Obstet Gynecol 1984;150:69-75
29. Kohorn EI: The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. Int J Gynecol Cancer 2001;11:73-77
30. Winquist E, Carey M: Activity of docetaxel in chemoresistant gestational choriocarcinoma. Gynecol Oncol 2000;79:523-524